Theophylline NDC 62135-556

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-556Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0556Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-556-24	62135055624	2 TRAY in 1 BOX (62135-556-24) / 10 CUP in 1 TRAY / 15 mL in 1 CUP (62135-556-51)Marketed from May 31, 2024
62135-556-47	62135055647	473 mL in 1 BOTTLE (62135-556-47)Marketed from Oct 27, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Theophylline
Generic name (nonproprietary): theophylline
Active ingredients: Theophylline anhydrous — 80 mg/15mL
Dosage form: Solution
Route: Oral
Labeler: Chartwell RX, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091156
Marketing start: Apr 13, 2011
Listing expires: Dec 31, 2027
Other FDA classes: Xanthines (Chemical structure)
Identifiers: Product ID 62135-556_4a2adbbe-acaa-a2bf-e063-6294a90a44c3SPL ID 4a2adbbe-acaa-a2bf-e063-6294a90a44c3SPL set ID 1b685384-5d96-46fa-b93b-e96538a2cfe7RxCUI 313306UNII 0I55128JYKUPC 0362135556471
Pharmacologic class: Methylxanthine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135055624 followed by a unit qualifier and the quantity

Package 62135-0556-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 6, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 091156

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091156
Product	Strength	Form · route	Labeler	Product NDC
Theophylline	Theophylline anhydrous 80 mg/15mL	SolutionOral	Chartwell Governmental & Specialty RX, LLC.	68999-556